Business
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standardsSAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) of its next-generation Tablo platform, designed to deliver enterprise-level security, reliability and
About this update from Outset Medical, Inc.
[{"type":"image","alt":"Outset Medical, Inc.","displaySize":"","headline":null,"caption":"Outset Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":150,"url":"https://media.zenfs.com/en/globenewswire.com/dbf72cbabf20edef2d3c5e04f8a2ce35"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/81TozlI2nSbjNuKd34NOOQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/dbf72cbabf20edef2d3c5e04f8a2ce35","width":300,"height":150}},"lazy":false},{"type":"text","content":"Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standards","length":88,"tagName":"p"},{"type":"text","content":"SAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) of its next-generation Tablo platform, designed to deliver enterprise-level security, reliability and connectivity for hospitals, health systems and home providers of dialysis.","length":486,"tagName":"p"},{"type":"text","content":"With the clearance, Tablo becomes the first hemodialysis system incorporating FDA’s most rigorous and recent guidance on medical device cybersecurity published in June 2025. Additionally, enhancements to the hardware, operating system and software have been designed to further enhance Tablo’s reliability and user experience.","length":326,"tagName":"p"},{"type":"text","content":"“We are proud to be the first dialysis company to clear the high standard for cybersecurity set by the FDA, a milestone that reflects Outset’s ongoing commitment to innovation, patient safety and data stewardship,” said Leslie Trigg, Chair and CEO. “Our next-generation platform is designed to protect and amplify the clinical, financial and operational value delivered to our customers, and extend Outset’s technology lead.”","length":425,"tagName":"p"},{"type":"text","content":"Next-Generation Tablo Platform The new Tablo platform is architected to offer enterprise-grade cybersecurity, reliability, and usability.","length":138,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Enterprise Cybersecurity: Security is embedded at the hardware, s...